ANRS 0140 EVOL-COV-AFRICA
Serological, clinical and mental health changes in paucisymptomatic/moderate COVID-19 patients in West Africa - EVOL-COV-AFRICA, a study linked to the ANRS COV01 INTENSE-COV and ANRS COV33 COVERAGE-AFRICA trials
Published on 27 February 2024
Primary objective
Biomedical Part: to describe changes in antibody titres after Covid-19 and the effect of vaccination on SARS-CoV-2 antibody titres.
Mental health Part: to evaluate patients’ experiences and mental health status during and after SARS-CoV-2 infection.
Theme
Covid-19
Status
Recruiting
Population
Adults
Samples
Serum
If you wish to access biological samples from this study:
Samples from the ANRS MIE BioBank are made available after the request is approved either by the Scientific Advisory Board if the study is ongoing, or by the Director of the ANRS MIE if the study has been completed.
For all requests, please fill in the form below and send it to the following address biobanque@anrs.fr
You are participating or have participated in this study
On the form above, you will find information on the ancillary studies for which your data/samples will be or may have been re-used if you gave your consent at the time of inclusion.
If you would like to find out more about your participation in a clinical study, please see the section below.
Visit the participant area